Definium Therapeutics, Inc.
NASDAQ:DFTXBiotechnology
Healthcare
$29.38 -1.67%
-$0.41 today
- Market cap
- $4.02B
- Beta
- 2.38
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$2.18
52W Low $12.88High $26.15
Volume 1.92M
Average 2.67M
Price history
Definium Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+157.49%
Period high
$48.45
Period low
$10.68
Latest
$29.38
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Nov 13, 2026 | Nov 13, 2026 | |
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| SC 13G | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Sep 29, 2026 | Sep 29, 2026 | |
| 4 | Sep 29, 2026 | Sep 29, 2026 | |
| 4 | Sep 29, 2026 | Sep 29, 2026 | |
| 4 | Sep 29, 2026 | Sep 29, 2026 | |
| 4 | Sep 29, 2026 | Sep 29, 2026 | |
| 4 | Sep 18, 2026 | Sep 18, 2026 | |
| 4 | Sep 18, 2026 | Sep 18, 2026 | |
| 4 | Sep 14, 2026 | Sep 14, 2026 | |
| 4 | Sep 14, 2026 | Sep 14, 2026 | |
| 4 | Sep 14, 2026 | Sep 14, 2026 | |
| 4 | Sep 14, 2026 | Sep 14, 2026 |
Competitors
Who does Definium Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about DFTX's filings, answered from its disclosures.
What is the latest DFTX filing?
The latest filing shown is SC 13G dated Nov 13, 2026.
How many recent filings does DFTX have?
Intrinsic Alpha currently shows 20 recent filings for DFTX.
Continue the stock analysis
Jump to another research area for this company.